Abu Dhabi, UAE, 16 June 2026: Elite Agro Holding, through its Moroccan subsidiary Elite Harvest Maroc, has inaugurated its seventh…
Read More
Mubadala Bio’s Wellpharma Secures Gulf Health Council Certification, Expanding Access Across the GCC
Abu Dhabi, UAE, June 2026: Mubadala Bio’s Wellpharma has successfully secured Gulf Health Council (GHC) certification, reinforcing its position as…
Read More
Esports World Cup 2026 to be Hosted in Paris, France
Paris becomes the first international EWC Host City outside of Riyadh, accelerating the Esports Foundation’s long-term global rotation ambition Bringing…
Read More
Ali & Sons Concludes Successful Participation at “Make it in the Emirates 2026”
The Group’s pavilion attracted significant interest from visitors across a wide range of industrial sectors, serving as a key platform…
Read More
Mubadala Bio’s IDS and Bayer Renew Partnership to Expand Access to Key Therapies Across the UAE
Abu Dhabi, UAE, 7 May 2026: Mubadala Bio, through its pharmaceutical logistics arm Al Ittihad Drug Store (IDS), has signed…
Read More
Mubadala Bio’s IDS and Bayer Renew Partnership to Expand Access to Key Therapies Across the UAE
Abu Dhabi, UAE, 7 May 2026: Mubadala Bio, through its pharmaceutical logistics arm Al Ittihad Drug Store (IDS), has signed…
Read More
Mubadala Bio’s IDS Signs Agreement with Valeo Health to Launch Online Channel for Consumer Health Products
Abu Dhabi, UAE, 6 May 2026: Mubadala Bio’s Al Ittihad Drug Store (IDS), has entered into an agreement with Valeo…
Read More
Dubai Global News Wins Two Prestigious Awards in 2026,
In a new milestone that reflects its continued success, Dubai Global News has been awarded two prestigious accolades for 2026:…
Read More
Mohammed bin Hamdan bin Zayed attends Kanad Hospital’s 65th anniversary celebration
His Excellency Sheikh Mohammed bin Hamdan bin Zayed Al Nahyan has attended the 65th anniversary celebration of Kanad Hospital, the…
Read More![مبادلة بايو تعزِّز الوصول إلى الأدوية الحيوية [FA1] لعلاج أمراض القلب والأوعية الدموية](https://i3.wp.com/dgnnewsportal.co.uk/wp-content/uploads/2026/03/WhatsApp-Image-2026-03-10-at-3.12.02-PM_result.webp?fit=1100,733&ssl=1 "مبادلة بايو تعزِّز الوصول إلى الأدوية الحيوية [FA1] لعلاج أمراض القلب والأوعية الدموية")
Mubadala Bio Expands Access to Critical Cardiovascular Medications
Mubadala Bio announced the launch of two new cardiovascular medications, ticagrelor and tirofiban, further expanding its portfolio in one of…
Read More
